With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 240 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
Legal 500, 2020
Chambers UK, 2020
Chambers Asia-Pacific, 2020
Chambers Europe, 2019
On 27 November 2020, the China National Intellectual Property Administration (“CNIPA”) issued the draft Implementing Regulations of the PRC Patent Law (“Draft Amendments for Implementing Regulations”) for public ...
On 23 November 2020, the Italian Revenue Agency published the new Administrative Provision n. 360494 (the “Provision”), endorsed in the Decree of the Ministry of Economy and Finance of 14 May 2018 (the “Decree”) which ...
The Legal 500: Pharmaceutical Advertising Guide 2021 is a practical cross-border insight into pharmaceutical advertising, with contributing editor Sally Shorthose.
We are delighted to announce that we received four prestigious awards at the Who’s Who Legal Awards 2020 held virtually in November.
Bird & Bird LLP advises Northern Green Canada Inc. (NGC) on its global expansion and the establishment of Northern Green Global GmbH, based in Unterschleissheim, Germany, which provides cannabinoid medicines to global ...
Bird & Bird has appointed Mikael Bock as Senior Counsel, strengthening its commercial offering in Sweden.
There are no forthcoming events for this area. Please click on the button below to view past events.
Hot off the press! Check out our newly published chapters for the @thelegal500 Pharmaceutical Advertising Country C… https://t.co/ckwEmAWTDy
Chinese patent linkage system – the Chinese Supreme Court issues Draft Judicial Interpretations:… https://t.co/eiHWKpnoUo
Managing Scientific Collaboration Agreements within the French Healthtech Sector: https://t.co/ZeQb4N8JkW https://t.co/1u34iYCZpC